Inventor · disambiguated record
Anders Nykjaer
Also filed as: NYKJAER ANDERS
12 granted patents·6 pending applications·103 citations·filing 2002–2021
91Inventor score
Top patents by PatentIndex Score
18 records- 0189US8815808B2Modulation of activity of neurotrophinsNYKJAER ANDERS·Filed 2011·Granted Aug 26, 2014·16 cites·8 claims
- 0288US9605073B2Modulation of activity of neurotrophinsH LUNDBECK·Filed 2015·Granted Mar 28, 2017·12 cites·5 claims
- 0387US8986690B2Modulation of activity of neurotrophinsNYKJAER ANDERS·Filed 2011·Granted Mar 24, 2015·12 cites·4 claims
- 0482US8066997B2Modulation of activity of neurotrophinsNYKJAER ANDERS·Filed 2003·Granted Nov 29, 2011·16 cites·5 claims
- 0581US9670263B2Modulation of the VPS10p-domain receptor family for the treatment of mental and behavioural disordersPEDERSEN SIMON GLERUP·Filed 2014·Granted Jun 6, 2017·11 cites·10 claims
- 0681US9234036B2Modulation of activity of proneurotrophinsLUNDBECK & CO AS H·Filed 2014·Granted Jan 12, 2016·10 cites·13 claims
- 0781US9084745B2Modulation of the Vps10p-domain for the treatment of cardiovascular diseaseNYKJAER ANDERS·Filed 2009·Granted Jul 21, 2015·10 cites·11 claims
- 0878US8748384B2Modulation of activity of proneurotrophinsANDERSEN OLAV MICHAEL·Filed 2007·Granted Jun 10, 2014·12 cites·9 claims
- 0971US9101117B2SorCS1-like agent for use in the treatment of insulin resistance and diseases related theretoPEDERSEN KAREN-MARIE·Filed 2010·Granted Aug 11, 2015·3 cites·18 claims
- 1064US9387232B2SorCS1 for the treatment of obesityPEDERSEN KAREN-MARIE·Filed 2011·Granted Jul 12, 2016·1 cites·19 claims
- 1155US2017158766A1Modulation of Activity of NeurotrophinsH LUNDBECK AS·Filed 2017·Application pending·0 cites
- 1254US10172918B2SorCS1 for the treatment of obesityUNIV AARHUS·Filed 2016·Granted Jan 8, 2019·0 cites·8 claims
- 1349US9931374B2SorCS1-like agent for use in the treatment of insulin resistance and diseases related theretoUNIV AARHUS·Filed 2015·Granted Apr 3, 2018·0 cites·10 claims
- 1447US2023144901A1Sortilin antagonists for use in the treatment of diabetic retinopathyINSUSENSE ApS·Filed 2021·Application pending·0 cites
- 1545US2017240611A1Modulation of the VPS10p-Domain Receptor Family for the Treatment of Mental and Behavioural DisordersH LUNDBECK AS·Filed 2017·Application pending·0 cites
- 1641US2007004727A1Use of compounds for the prevention of drug-induced cell toxicityRECEPTION APS C O OSTYSK INNOV·Filed 2004·Application pending·0 cites
- 1739US2009110720A1Use of compounds for the prevention of drug-induced cell toxicityNYKJAER ANDERS·Filed 2005·Application pending·0 cites
- 1827US2004198705A1Modulation of steroid hormone uptakeFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Anders Nykjaer files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →